190 related articles for article (PubMed ID: 20657316)
1. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
Lusis EA; Travers S; Jost SC; Perry A
Neurosurgery; 2010 Sep; 67(3):811-7; discussion 817. PubMed ID: 20657316
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
3. Turcot syndrome type 2: medulloblastoma with multiple colorectal adenomas.
Skomorowski M; Taxier M; Wise W
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):A24. PubMed ID: 22732270
[No Abstract] [Full Text] [Related]
4. Turcot syndrome: case report and nosological aspects.
Fracasso P; Caviglia R; Grassi A; Lapenta R; Stigliano V; Franco D; Casale V
J Exp Clin Cancer Res; 1997 Dec; 16(4):433-5. PubMed ID: 9505220
[TBL] [Abstract][Full Text] [Related]
5. Gliosarcoma with prominent smooth muscle component (gliomyosarcoma): a report of 10 cases.
Khanna M; Siraj F; Chopra P; Bhalla S; Roy S
Indian J Pathol Microbiol; 2011; 54(1):51-4. PubMed ID: 21393877
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
7. Concomitant IDH wild-type glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.
Galuppini F; Opocher E; Tabori U; Mammi I; Edwards M; Campbell B; Kelly J; Viel A; Quaia M; Rivieri F; D'Avella D; Arcella A; Giangaspero F; Fassan M; Gardiman MP
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):233-239. PubMed ID: 29130549
[No Abstract] [Full Text] [Related]
8. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
9. Turcot syndrome: a case report in an unsuspected setting.
Chung HJ; Oh ST; Kim JG; Kang WK
J Gastrointest Surg; 2012 Feb; 16(2):411-4. PubMed ID: 21959784
[No Abstract] [Full Text] [Related]
10. A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.
Funata N; Nobusawa S; Yamada R; Shinoura N
Brain Tumor Pathol; 2016 Jan; 33(1):57-62. PubMed ID: 26602910
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
[TBL] [Abstract][Full Text] [Related]
12. [Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].
Iza B; Mateo-Sierra O; Ruiz-Juretszke F; Garbizu J; Guzmán de Villoria J; Carrillo R
Neurocirugia (Astur); 2006 Aug; 17(4):340-6; discussion 346-7. PubMed ID: 16960645
[TBL] [Abstract][Full Text] [Related]
13. A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndrome.
Fritch Lilla SA; Yi JS; Hall BA; Moertel CL
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e177-9. PubMed ID: 24309598
[TBL] [Abstract][Full Text] [Related]
14. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Rodriguez FJ; Scheithauer BW; Giannini C; Bryant SC; Jenkins RB
Cancer; 2008 Nov; 113(10):2779-89. PubMed ID: 18816605
[TBL] [Abstract][Full Text] [Related]
15. Giant infantile gliosarcoma: magnetic resonance imaging findings.
Sanal HT; Bulakbasi N; Kocaoglu M; Onguru O; Chen L
J Child Neurol; 2008 Aug; 23(8):926-9. PubMed ID: 18403585
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
17. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
18. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
19. Two different primary brain tumors, glioblastoma multiforme and pituitary adenoma, in association with colorectal carcinoma: an unusual case of nonfamilial Turcot's syndrome?
Naydenov E; Marinov M; Nachev S
J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):410-2. PubMed ID: 21735373
[No Abstract] [Full Text] [Related]
20. [Contacts and superpositions between Zulch's mostrovellular sarcoma and glioblastoma mutiforme].
Colafranceshi M; Ambrosi L
Arch De Vecchi Anat Patol; 1967 Dec; 50(3):873-90. PubMed ID: 4377205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
